Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Financials (€)
Sales 2017 246 M
EBIT 2017 46,2 M
Net income 2017 28,9 M
Debt 2017 103 M
Yield 2017 -
P/E ratio 2017 73,93
P/E ratio 2018 50,75
EV / Sales 2017 9,41x
EV / Sales 2018 7,01x
Capitalization 2 208 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | EVT | DE0005664809 | 4-Traders
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 17,5 €
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG74.01%2 611
CELLTRION, INC.--.--%23 699
IQVIA HOLDINGS INC32.70%21 261
INCYTE CORPORATION-3.68%20 703
LONZA GROUP57.44%20 102
ALNYLAM PHARMACEUTICALS, INC.249.60%12 278